SS-31: Clinical Trials & Research

0 registered clinical trials and 113 peer-reviewed publications indexed for SS-31, sourced from ClinicalTrials.gov and PubMed.

Research papers

• Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence
• Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic…
• Elamipretide: a mitochondria-targeting drug for Barth syndrome
• Elamipretide in pediatric Barth syndrome: from heart failure to school return
• Pre-qualifications, learning strategies, and study satisfaction among medical students: insights from a multicenter…

See also: SS-31 full profile.

Study summaries on this site: Elamipretide in pediatric Barth syndrome: from heart failure to school return, Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets…, Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence, Pre-qualifications, learning strategies, and study satisfaction among medical students:…, Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and….